Provider Groups File Appellate Briefs in Key 340B Contract Pharmacy Cases

Groups representing health centers, HIV/AIDS clinics, and hospitals filed briefs in key 340B contract pharmacy cases in federal appeals courts in Washington, D.C., and Philadelphia.

Groups representing health centers, HIV/AIDS clinics, and hospitals asked federal appeals courts in Philadelphia and Washington, D.C., this week to hold that drug manufacturers must give covered entities 340B discounts on drugs when entities use contract pharmacies to

Read More »

With Screws Tightening on 340B Contract Pharmacy, More Health Centers Plan to Open their Own

One-third of health center leaders whose centers do not have an on-site pharmacy say they plan to open one in the next three years, a survey by 340B pharmacy management company Maxor 340B found.

One-third (33%) of community health center (CHC) senior executives whose organizations do not currently have an on-site pharmacy plan to open one in the next three years, a new survey shows.

Please Login or

Read More »

State Bill That Would Have Stopped Drug Industry from Imposing 340B Contract Pharmacy Restrictions Dies

A 340B anti-discrimination bill targeting pharmacy benefit managers and drug manufacturers failed to advance in Connecticut.

Legislation in Connecticut that would have kept drug manufacturers from imposing “any preconditions, limitations, delays or other barriers” to 340B drug purchases “that are not required” by the 340B statute, died when this year’s legislative session ended on

Read More »

Colorado Lawmakers Pass 340B Anti-discrimination Bill

Colorado lawmakers voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

The Colorado General Assembly has voted to stop health insurers, pharmacy benefit managers (PBMs), and other third-party payers from discriminating against 340B covered entities and their contract pharmacies.

Please Login or Become a Paid

Read More »

U.S. Uninsured Rate Dipped Slightly in 2021 to 9.2% but Rates for Hispanics and Blacks Remain High

The U.S. uninsured rate fell slightly in 2021 to 9.2%, down from 9.7% in 2020, new data from the National Center for Health Statistics (NCHS) show.

The U.S. uninsured rate fell slightly in 2021 to 9.2% (about 30 million people), down from 9.7% (about 31.6 million people) in 2020, the National Center for Health Statistics (NCHS) reports.

Please Login or

Read More »

25 States Say Drug Companies’ 340B Contract Pharmacy Actions Are Illegal and Harm Public Health

An excerpt from one of the two friend of the court briefs that 25 states filed in pivotal 340B contract pharmacy litigation in federal appeals courts.

Drug manufacturers’ conditions on 340B pricing when covered entities use contract pharmacies violate federal law and ultimately diminish states’ public health efforts, 25 states told two federal appeals courts yesterday.

Please Login or Become

Read More »

GOP-aligned Think Tank Alleges that 340B Expansions Contributed to Drug Spending Spurts

The American Action Forum says "it is worthwhile to consider whether" there is a link between the implementation of 340B policies and upswings in retail drug spending. A drug policy experts who found that that inflation penalties in the 340B program were associated with lower annual drug price increases says AAF's analysis "is specious at best."

An American Action Forum (AAF) data analysis that connects increases in consumer drug spending with the introduction of 340B drug discount and Medicaid drug rebate program policies “is spurious at best,” says an expert on prescription drug costs

Read More »

HRSA Announces 340B Enrollment Flexibilities in Fire-Ravished New Mexico

HRSA has announced 340B program enrollment flexibilities in New Mexico, which is coping with the biggest wildfire in state history.

The U.S. Health Resources and Services Administration (HRSA) yesterday announced 340B program enrollment flexibilities in New Mexico due to the declaration of a public health emergency in the state.

Please Login or Become a

Read More »

News Alert

25 States File Joint Briefs Backing HHS and HRSA in 340B Contract Pharmacy Cases

Connecticut Attorney General William Tong (D) led the coalition of states backing the federal government in 340B contract pharmacy cases before federal appeals courts.

Twenty-five states are backing the federal government in litigation before two federal appeals courts over drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.

Please Login or Become a Paid Subscriber

Read More »

Mallinckrodt Is the Third Drug Company This Month to Announce Refunds for 340B Overcharges

Mallinckrodt's SpecGx subsidiary is providing refunds for 340B overcharges on 22 NDCs for purchases from Q3 2019 through Q2 2020.

Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary is providing refunds for 340B overcharges on 22 NDCs for purchases from Q3 2019 through Q2 2020.

Please Login or Become a Paid Subscriber to View this

Read More »
Generic selectors
Exact matches only
Search in title
Search in content